Novo Nordisk's pricing techniques inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of cost gouging, stating the stark contrast concerning U.S. prices and people in Europe and copyright. This led Novo Nordisk to carry out further